Search Results for: Cybin

A recently published review has determined that using psilocybin to manage mental-health conditions doesn’t heighten the risk of paranoia. This discovery comes at a time when public interest in the therapeutic potential of psychedelics is increasing. The review was carried out by researchers at Larkin University, the University of Georgia and Palm Beach Atlantic University, … Continue reading “AMA Study Finds Treating Mental-Health Issues with Psilocybin Doesn’t Increase Paranoia Risk”

Diabetes is a chronic illness characterized by high levels of blood sugar. There are different types of diabetes, the most common being types I and II. Latest data estimates that by 2045, more than 700 million individuals globally could be afflicted with the illness as its prevalence continued to rise. Researchers have commenced studies into … Continue reading “Psilocybin Could Help in Combating Diabetes”

Legislators in the House of Representatives in the state of Missouri have awarded preliminary approval to a budget measure that would allocate $10 million from opioid settlement funds to study grants focused on researching psilocybin’s use in treating opioid-use disorder. The initiative, HB 2010, was amended in the House. One amendment made in a committee … Continue reading “Missouri to Use $10M from Opioid Funds to Study Psilocybin”

Governor Eric Holcomb of Indiana recently signed a measure that includes provisions to fund clinical trials on psilocybin’s therapeutic benefits. The measure, which primarily focuses on healthcare issues, was recently amended to include language on psychedelics. The reform provisions that legislators included to the broader measure were obtained from a standalone bill from Senator Ed … Continue reading “Indiana Governor Enacts Bill Funding Psilocybin Research for First Responders, Veterans”

University of Calgary scientists want to conduct a trial on the use of psilocybin as a treatment for alcohol use disorder (AUD). The trial will be carried out at the Hotchkiss Brain Institute and will include 128 individuals with alcohol use disorder. Each of the participants will undergo sessions prior to and after treatment; they … Continue reading “University of Calgary Researchers Begin Testing Psilocybin as AUD Treatment”

New research has discovered that psilocybin decreases the amygdala region’s response to seeing images of angry faces. The amygdala is responsible for processing emotions, particularly those linked to anxiety and fear. This region in the brain also links emotions to other things such as senses, memories and learning. This region’s activity affects social interactions as … Continue reading “Study Shows Psilocybin Reduces Brain’s Reaction to Angry Faces”

Hawaii recently introduced a new measure that would establish legal protections for psilocybin’s therapeutic use. Under SB 3019, eligible patients would be allowed to possess the psychedelic and receive it under the care of a trained facilitator. The legislation, which was sponsored by Senator Chris Lee, was introduced by a task force formed in 2023 … Continue reading “Hawaii Task Force Files Bill Creating Program for Medicinal Psilocybin Use”

Researchers from the University of Southern Denmark have discovered that microdoses of psilocybin, the main psychoactive agent in mushrooms, may be able to alleviate anhedonia. The study used a mouse study to discover that regular small doses of the psychedelic may offer therapeutic benefits against stress-induced anhedonia, a condition that strips individuals of their ability … Continue reading “Mouse Study Shows Microdoses of Psilocybin Can Combat Anhedonia”